News
The July 1 quarterly HCPCS Level II update includes several drug/biological code changes, according to an AAPC release.
Effective from 1 October 2025, CMS and commercial health insurers will recognise the HCPCS Level II code A9616 assigned for reimbursement of Gozellix.
Effective from 1 October 2025, CMS and commercial health insurers will recognise the HCPCS Level II code A9616 assigned for reimbursement of Gozellix. The assignment of the code is a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback